The Effect of Tang Ning Tongluo Formula in Type 2 Diabetics Clinical Analysis
NCT ID: NCT02174042
Last Updated: 2014-09-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
120 participants
INTERVENTIONAL
2014-03-31
2014-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Integrated Clinical Evaluation of Traditional Chinese Medicine (TCM) and Conventional Medicine on Diabetic Patients
NCT02564913
TCM and Nutrition for Diabetes Care Cohort
NCT05312450
Effect of Compound Danshen Dripping Pills on Diabetic Patients With Coronary Microcirculation Disturbance
NCT05295329
The Long-term Effect of Tianqi Capsule Interventions to Prevent Diabetes in the REDUCES Study: a 8-year Follow-up Study
NCT02848053
Tangningtongluo Tablet for People With Prediabetes
NCT05126251
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Tangning Tongluo Capsule
Type 2 diabetes
Tangning Tongluo Capsule
Taken drugs 3 times a day, with each time 3 grains
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Tangning Tongluo Capsule
Taken drugs 3 times a day, with each time 3 grains
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. the sustained follow-up time \>3 month.
3. TNTL single or combined treatment time \>3 month.
4. Chinese ethnicity.
Exclusion Criteria
2. lactating or pregnant.
3. diagnosis of heart failure, acute myocardial infarction, stroke, or serious injuries.
4. any other conditions not suitable for trial as evaluated by the physician in charge.
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Guizhou Bailing Group Pharmaceutical Co Ltd
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wenshu Teng, Dr.
Role: STUDY_DIRECTOR
ICMJE
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nanmeng Tianyuan hospital; Dongfang Hospital; China-Japanese Friendship Hospital
Beijing Shi, Guizhou, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TNTL-14-03
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.